Cas:18080-67-6 2,3-bis(bromomethyl)quinoxaline-1,4-dioxide manufacturer & supplier

Chemical Name:2,3-bis(bromomethyl)quinoxaline-1,4-dioxide

CAS.NO:18080-67-6

Synonyms:2,3-bis(bromomethyl)quinoxaline-1,4-dioxide;quinoxaline, 2,3-bis(bromomethyl)-, 1,4-dioxide;Quinoxalinium, 2,3-bis(bromomethyl)-1,4-dihydro-4-hydroxy-1-oxo-, inner salt;2,3-Bis-bromomethyl-quinoxaline 1,4-dioxide;2,3-Bis(bromomethyl)-1-oxoquinoxalin-1-ium-4(1H)-olate;2,3-Bis-brommethyl-chinoxalin-1,4-dioxid

Molecular Formula:C₁₀H₈Br₂N₂O₂

Molecular Weight:347.991

HS Code:2933990090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:50.92000

Exact Mass:345.895233

LogP:3.48660

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2,3-bis(bromomethyl)quinoxaline-1,4-dioxide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,3-Bis-brommethyl-chinoxalin-1,4-dioxid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,3-bis(bromomethyl)quinoxaline-1,4-dioxide Use and application,2,3-bis(bromomethyl)quinoxaline-1,4-dioxide technical grade,usp/ep/jp grade.

Related News: Beta Bionics is a for-profit Massachusetts public benefit corporation founded in 2015 to commercialize the iLet, a revolutionary bionic pancreas that is driven by mathematical dosing algorithms, which incorporate lifelong autonomous learning to automatically control glycemia. 2,3-bis(bromomethyl)quinoxaline-1,4-dioxide manufacturer It is foreseeable that in the future, the capacity and output of bulk APIs in China will decrease, the supply-demand relationship will be balanced, and prices and profits will gradually return to a more reasonable range. The era of low prices in the past will be gone forever. Individual APIs Varieties may even lose their price competitive advantage and move abroad. 2,3-bis(bromomethyl)quinoxaline-1,4-dioxide supplier The CTSuccess service uses Catalent��s proprietary StartScoreTM evaluation tool to calculate the complexity of a potential clinical project across more than a dozen specific and objective study characteristics. 2,3-bis(bromomethyl)quinoxaline-1,4-dioxide vendor It is foreseeable that in the future, the capacity and output of bulk APIs in China will decrease, the supply-demand relationship will be balanced, and prices and profits will gradually return to a more reasonable range. The era of low prices in the past will be gone forever. Individual APIs Varieties may even lose their price competitive advantage and move abroad. 2,3-bis(bromomethyl)quinoxaline-1,4-dioxide factory In order to seize the highest point of profits, international industry giants have adjusted their development strategies, concentrated their energies on the two ends of the smile curve-research and development and end products, and shifted production links such as intermediates and APIs outward. A division of labor model has been formed.